Cargando…
Author Correction: Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
Autores principales: | Chen, Yuxi, Liu, Jiaqi, Zhi, Shengyao, Zheng, Qi, Ma, Wenbin, Huang, Junjiu, Liu, Yizhi, Liu, Dan, Liang, Puping, Songyang, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347611/ https://www.ncbi.nlm.nih.gov/pubmed/32647138 http://dx.doi.org/10.1038/s41467-020-17379-y |
Ejemplares similares
-
Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
por: Chen, Yuxi, et al.
Publicado: (2020) -
Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons
por: Chen, Yuxi, et al.
Publicado: (2020) -
CRISPR/Cas9 Promotes Functional Study of Testis Specific X-Linked Gene In Vivo
por: Li, Minyan, et al.
Publicado: (2015) -
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
por: Liang, Puping, et al.
Publicado: (2015) -
CRISPR-assisted transcription activation by phase-separation proteins
por: Liu, Jiaqi, et al.
Publicado: (2023)